Indian Pacing Electrophysiol J
December 2019
Purpose: The Biotronik Linox DX implanted cardioverter defibrillator (ICD) lead is a novel VDD lead with the advantage of integrated atrial sensing dipole combined with a special augmentation and filtering mechanisms. We sought to determine the efficacy of the Biotronik Linox DX ICD lead.
Methods: Non-randomized consecutive patients implanted with Biotronik Linox DX lead at Sheba Medical Center were included in this study.
Pacing Clin Electrophysiol
December 2019
Background: An early failure of Biotronik Linox implantable cardioverter defibrillator (ICD) leads has been reported from several centers.
Aim: To compare the performance of Linox ICD leads with different other ICD leads as a report of the Sheba Medical Center experience.
Methods: All patients who had implantation of Linox ICD leads between 2007 and 2016 were included in this study.
Background: Catheter ablation (CA) is a well-established therapeutic option for patients with recurrent symptomatic atrial fibrillation (AF). Data on gender-related differences are limited with regard to baseline characteristics and long-term success rates of catheter ablation for AF.
Methods: We analyzed a cohort of 251 consecutive patients who underwent a first catheter ablation for AF in our institute during the period 2008 through 2015.
Papillary muscles (PMs) were reported to be origin of ventricular arrhythmia (VA). Radiofrequency (RF) ablation was reported to be acutely effective in eliminating VA. However, the recurrence rate is high.
View Article and Find Full Text PDFIntroduction: Renal dysfunction is associated with increased morbi-mortality in heart failure patients. Data regarding functional and clinical efficacy of cardiac resynchronization therapy (CRT) in this population are limited.
Methods And Results: We aimed to evaluate the rate of functional response to CRT in patients with renal dysfunction and its association with long-term mortality.